Dr. Lal PathLabs [LALPATHLAB] vs Vijaya Diagnostic [VIJAYA] Detailed Stock Comparison

Dr. Lal PathLabs

NSE

Vijaya Diagnostic

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dr. Lal PathLabs wins in 13 metrics, Vijaya Diagnostic wins in 7 metrics, with 0 ties. Dr. Lal PathLabs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Dr. Lal PathLabs	Vijaya Diagnostic	Better
P/E Ratio (TTM)	52.48	70.16	Dr. Lal PathLabs
Price-to-Book Ratio	12.39	13.20	Dr. Lal PathLabs
Debt-to-Equity Ratio	7.14	39.99	Dr. Lal PathLabs
PEG Ratio	2.17	3.07	Dr. Lal PathLabs
EV/EBITDA	38.67	36.80	Vijaya Diagnostic
Profit Margin (TTM)	20.29%	21.04%	Vijaya Diagnostic
Operating Margin (TTM)	23.54%	27.99%	Vijaya Diagnostic
EBITDA Margin (TTM)	23.54%	27.99%	Vijaya Diagnostic
Return on Equity	22.08%	17.90%	Dr. Lal PathLabs
Return on Assets (TTM)	17.93%	11.23%	Dr. Lal PathLabs
Free Cash Flow (TTM)	$5.15B	$1.29B	Dr. Lal PathLabs
Dividend Yield	0.93%	0.30%	Dr. Lal PathLabs
1-Year Return	-1.75%	18.49%	Vijaya Diagnostic
Price-to-Sales Ratio (TTM)	10.65	14.76	Dr. Lal PathLabs
Enterprise Value	$263.06B	$107.31B	Dr. Lal PathLabs
EV/Revenue Ratio	10.40	15.05	Dr. Lal PathLabs
Gross Profit Margin (TTM)	66.99%	88.61%	Vijaya Diagnostic
Revenue per Share (TTM)	$303	$70	Dr. Lal PathLabs
Earnings per Share (Diluted)	$61.52	$14.61	Dr. Lal PathLabs
Beta (Stock Volatility)	0.08	-0.10	Vijaya Diagnostic

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Dr. Lal PathLabs vs Vijaya Diagnostic Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Dr. Lal PathLabs	-2.10%	-0.12%	7.08%	16.45%	39.08%	8.72%
Vijaya Diagnostic	1.63%	9.49%	0.27%	12.98%	9.33%	2.51%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Dr. Lal PathLabs	-1.75%	31.10%	80.50%	270.45%	270.45%	270.45%
Vijaya Diagnostic	18.49%	144.18%	73.75%	73.75%	73.75%	73.75%

Performance & Financial Health Analysis: Dr. Lal PathLabs vs Vijaya Diagnostic

Metric	LALPATHLAB	VIJAYA
Market Information
Market Cap i	₹195.86B	₹109.57B
Market Cap Category	Mid cap	Mid cap
10 Day Avg. Volume i	120,229	200,623
90 Day Avg. Volume i	120,707	448,362
Last Close	₹3,249.60	₹1,107.20
52 Week Range	₹2,293.55 - ₹3,653.95	₹740.00 - ₹1,275.00
% from 52W High	-11.07%	-13.16%
All-Time High	₹4,245.50 (Sep 13, 2021)	₹1,275.00 (Jan 13, 2025)
% from All-Time High	-23.46%	-13.16%
Growth Metrics
Quarterly Revenue Growth	0.11%	0.20%
Quarterly Earnings Growth	0.24%	0.22%
Financial Health
Profit Margin (TTM) i	0.20%	0.21%
Operating Margin (TTM) i	0.24%	0.28%
Return on Equity (TTM) i	0.22%	0.18%
Debt to Equity (MRQ) i	7.14	39.99
Cash & Liquidity
Book Value per Share (MRQ)	₹260.62	₹77.65
Cash per Share (MRQ)	₹139.63	₹22.90
Operating Cash Flow (TTM) i	₹4.66B	₹2.04B
Levered Free Cash Flow (TTM) i	₹4.87B	₹1.43B
Dividends
Last 12-Month Dividend Yield i	0.93%	0.30%
Last 12-Month Dividend i	₹30.00	₹3.00

Valuation & Enterprise Metrics Analysis: Dr. Lal PathLabs vs Vijaya Diagnostic

Metric	LALPATHLAB	VIJAYA
Price Ratios
P/E Ratio (TTM) i	52.48	70.16
Forward P/E i	109.88	51.46
PEG Ratio i	2.17	3.07
Price to Sales (TTM) i	10.65	14.76
Price to Book (MRQ) i	12.39	13.20
Market Capitalization
Market Capitalization i	₹195.86B	₹109.57B
Enterprise Value i	₹263.06B	₹107.31B
Enterprise Value Metrics
Enterprise to Revenue i	10.40	15.05
Enterprise to EBITDA i	38.67	36.80
Risk & Other Metrics
Beta i	0.08	-0.10
Book Value per Share (MRQ) i	₹260.62	₹77.65

Financial Statements Comparison: Dr. Lal PathLabs vs Vijaya Diagnostic

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	LALPATHLAB	VIJAYA
Revenue/Sales i	₹6.70B	₹1.88B
Cost of Goods Sold i	₹2.21B	₹214.13M
Gross Profit i	₹4.49B	₹1.67B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹1.58B	₹526.44M
EBITDA i	₹2.20B	₹805.82M
Pre-Tax Income i	₹1.81B	₹522.07M
Income Tax i	₹471.00M	₹136.18M
Net Income (Profit) i	₹1.34B	₹385.89M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	LALPATHLAB	VIJAYA
Cash & Equivalents i	₹2.93B	₹128.01M
Total Current Assets i	₹13.64B	₹3.07B
Total Current Liabilities i	₹4.02B	₹1.63B
Long-Term Debt i	₹1.03B	₹2.96B
Total Shareholders Equity i	₹22.06B	₹7.99B
Retained Earnings i	₹18.60B	N/A
Property, Plant & Equipment i	₹3.36B	₹7.24B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	LALPATHLAB	VIJAYA
Operating Cash Flow i	N/A	₹282.28M
Capital Expenditures i	N/A	₹-648.48M
Free Cash Flow i	N/A	₹-321.75M
Debt Repayment i	N/A	₹-2.72M
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	LALPATHLAB	VIJAYA
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	120,229	200,623
Average Daily Volume (90 Day) i	120,707	448,362
Shares Outstanding i	83.37M	102.64M
Float Shares i	37.19M	46.83M
% Held by Insiders i	0.57%	0.53%
% Held by Institutions i	0.32%	0.39%

Dividend Analysis & Yield Comparison: Dr. Lal PathLabs vs Vijaya Diagnostic

Metric	LALPATHLAB	VIJAYA
Last 12-Month Dividend i	₹30.00	₹3.00
Last 12-Month Dividend Yield i	0.93%	0.30%
3-Year Avg Annual Dividend i	₹20.00	₹1.67
3-Year Avg Dividend Yield i	0.28%	0.19%
3-Year Total Dividends i	₹60.00	₹5.00
Ex-Dividend Date	Aug 06, 2025	Aug 29, 2025